Insider Transactions in Q1 2024 at Singular Genomics Systems, Inc. (OMIC)
Insider Transaction List (Q1 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 15
2024
|
Andrew Spaventa Chief Executive Officer |
BUY
Bona fide gift
|
Indirect |
14,583
+0.36%
|
-
|
|
Mar 15
2024
|
Andrew Spaventa Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
14,583
-59.89%
|
-
|
|
Mar 15
2024
|
Andrew Spaventa Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
14,583
+37.46%
|
-
|
|
Mar 15
2024
|
Eli N. Glezer Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,500
+0.16%
|
-
|
|
Mar 15
2024
|
Dalen Meeter Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,250
+3.03%
|
-
|
|
Mar 15
2024
|
Sam Ropp Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,187
+20.0%
|
-
|